A detailed history of Rinkey Investments transactions in Ocugen, Inc. stock. As of the latest transaction made, Rinkey Investments holds 1,164,506 shares of OCGN stock, worth $1.12 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,164,506
Holding current value
$1.12 Million
% of portfolio
0.26%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$0.52 - $0.9 $605,543 - $1.05 Million
1,164,506 New
1,164,506 $826,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $208M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Rinkey Investments Portfolio

Follow Rinkey Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rinkey Investments, based on Form 13F filings with the SEC.

News

Stay updated on Rinkey Investments with notifications on news.